Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 103
Filter
1.
Clin Otolaryngol ; 43(1): 96-102, 2018 02.
Article in English | MEDLINE | ID: mdl-28585263

ABSTRACT

OBJECTIVES: To evaluate the effectiveness of interventional sialendoscopy alone or combined with outpatient intraductal steroid irrigations in patients with sialadenitis due to Sjögren's syndrome (SS). DESIGN: A pilot therapeutic study. SETTING: ENT Clinics, Universities of Milan and Pavia. STUDY POPULATION: We included 22 patients with SS of whom 12 underwent interventional sialendoscopy followed by intraductal steroid irrigations (group A), and 10 interventional sialendoscopy alone (group B). OUTCOMES MEASURES: The following outcome measures were considered and recorded before and after the therapeutic intervention: (i) number of episodes of glandular swelling, (ii) cumulative prevalence of patients with glandular swelling assessed by the specific domain, the EULAR SS Disease Activity Index (ESSDAI), (iii) severity of pain by means of a 0-10 pain visual analogue scale (VAS), (iv) severity of xerostomia and other disease symptoms assessed by the EULAR SS Patient Reported Index (ESSPRI) and the Xerostomia Inventory questionnaire. RESULTS: The postoperative reduction in the mean number of episodes of glandular swelling was 87% (95% CI: 77-93) and 75% (95% CI: 47%-88%) in the groups A and B, respectively. The percentage of patients with glandular swelling decreased from 41.7% to 0.0% in the group A and from 30.0% to 0.0% in the group B, respectively. Most of the patients experienced a subjective clinical improvement documented by the statistically significant reductions in the postoperative mean pain VAS (group A P<.001; group B P=.004), Xerostomia Inventory (P<.001 and P=.003) and ESSPRI scores (P<.001 and P=.008). Interventional sialendoscopy followed by outpatient intraductal steroid irrigations was more effective than interventional sialendoscopy alone, when pain VAS, Xerostomia Inventory and ESSPRI scores before and after treatment were analysed together using the multivariate Hotelling T2 test (P=.0173). CONCLUSIONS: This pilot study confirms that interventional sialendoscopy with steroid duct irrigation significantly reduces the number of painful episodes of sialadenitis and improves the subjective sensation of oral dryness and other disease symptoms in patients with SS. The study results also suggest that the improvement is greater when interventional sialendoscopy is combined with a cycle of outpatient steroid ductal irrigations. Larger controlled randomised studies are certainly needed to confirm these preliminary data.


Subject(s)
Endoscopy/methods , Glucocorticoids/administration & dosage , Salivary Ducts/diagnostic imaging , Sialadenitis/diagnosis , Sjogren's Syndrome/complications , Aged , Chronic Disease , Female , Follow-Up Studies , Humans , Male , Pilot Projects , Recurrence , Retrospective Studies , Severity of Illness Index , Sialadenitis/drug therapy , Sialadenitis/etiology , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/drug therapy , Treatment Outcome
2.
Bone Marrow Transplant ; 52(1): 53-58, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27548467

ABSTRACT

We retrospectively evaluated the efficacy of autologous hematopoietic stem cell transplantation (AHSCT) in 18 patients with rapidly progressive diffuse cutaneous systemic sclerosis (rp-dcSSc), and compared their disease outcomes with those of 36 demographically- and clinically-matched patients treated with conventional therapies. Cutaneous involvement, by performing modified Rodnan skin score (mRss), lung diffusion capacity, by measuring diffusing capacity of lung for carbon monoxide (DLCO), and disease activity, by applying the European Scleroderma Study Group (ESSG) scoring system, were the outcome variables measured at the baseline time and then every 12 months for the following 60 months in both the AHSCT-treated patients and the control group. In the AHSCT group, treatment-related mortality was 5.6%. In this group, both mRss and ESSG scores showed a significant reduction 1 year after AHSCT (P<0.002); and these results were maintained until the end of follow-up. Conversely, DLCO values remained stable during the whole period of follow-up. Survival rate of AHSCT group was much higher than that observed in the whole control group (P=0.0005). The probability that the ESSG score and mRss would remain at a high level, and DLCO could decrease, was significantly higher in the control group as a whole and in the subgroup of control patients treated with cyclophosphamide than in the AHSCT group. This study confirms that the AHSCT is effective in prolonging survival, as well as in inducing a rapid reduction of skin involvement and disease activity, and preserving lung function in patients with rp-dcSSc.


Subject(s)
Hematopoietic Stem Cell Transplantation , Scleroderma, Diffuse/mortality , Scleroderma, Diffuse/therapy , Adult , Autografts , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Survival Rate
3.
Curr Med Chem ; 17(28): 3289-95, 2010.
Article in English | MEDLINE | ID: mdl-20666717

ABSTRACT

The aim of this study was to verify the existence of synergistic antibacterial effect between four essential oils (Aniba rosaeodora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens) individually combined with the antibacterial drug Gentamicin. We investigated the effectiveness in vitro of the association of essential oil/Gentamicin, against fifteen different strains of Gram positive and Gram negative bacteria. The antibacterial effects of these oils in combination with Gentamicin were evaluated by using the MHB microdilution method, while gas chromatography (GC) and GC/Mass spectrometry were used to analyze the chemical composition of the oils. A synergistic interaction was observed against all tested strains with the associations between the essential oils Aniba rosaeodora/Gentamicin and Pelargonium graveolens/Gentamicin. In particular a very strong synergistic interaction was observed against Acinetobacter baumannii ATCC 19606 (FIC index = 0.11). In contrast, the essential oils Origanum vulgare and Melaleuca alternifolia in association with Gentamicin were less effective on bacterial species growth. In vitro interaction can improve the antimicrobial effectiveness of the Gentamicin and may contribute to reduce its dose correlated to side effects.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gentamicins/pharmacology , Oils, Volatile/pharmacology , Drug Combinations , Drug Synergism , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Microbial Sensitivity Tests
4.
Rev Chilena Infectol ; 24(1): 68-71, 2007 Feb.
Article in Spanish | MEDLINE | ID: mdl-17369975

ABSTRACT

In patients with human immunodeficiency virus infection, pneumothorax overcomes in advanced stages of the illness, associated with infections by Mycobacterium tuberculosis or Pneumocystis jiroveci, in smokers and intravenous drug users. We present a case with this unusual complication: homosexual man, 30 years of age, with a history of one month of cough, progressive dyspnea, weight loss and diarrhea. He was hospitalized with the diagnosis of atypical pneumonia, respiratory failure and a presumptive HIV infection. His clinical course was complicated by the presence of bullae and pneumothorax by day 15 of hospitalization. The existence of Pneumocystis jiroveci in sputum was confirmed by a direct immunofluorescence test. The patient was treated with sulpha-trimethoprim, steroids, oxygen, but he died 21 days after admittance. The strategies recommended for treatment of pneumothorax appeared during P. jiroveci pneumonia in HIV positive patients are summarized.


Subject(s)
AIDS-Related Opportunistic Infections/complications , Pneumocystis carinii , Pneumonia, Pneumocystis/complications , Pneumothorax/etiology , AIDS-Related Opportunistic Infections/drug therapy , Adult , Fatal Outcome , Fluorescent Antibody Technique, Indirect , Humans , Male , Pneumonia, Pneumocystis/drug therapy , Tomography, X-Ray Computed
5.
Rev. chil. infectol ; 24(1): 68-71, feb. 2007. ilus
Article in Spanish | LILACS | ID: lil-443062

ABSTRACT

En los pacientes con infección por el virus de la inmunodeficiencia humana (VIH), el neumotórax se observa generalmente en etapas avanzadas de la enfermedad, asociado a patógenos como Mycobacterium tuberculosis o Pneumocystis jiroveci, en individuos tabáquicos y drogadictos endovenosos. Presentamos un caso de presentación inhabitual: varón homosexual, 30 años de edad, con tos durante un mes, dificultad respiratoria progresiva y baja de peso, agregándose posteriormente diarrea. Fue hospitalizado con los diagnósticos de insuficiencia respiratoria, neumopatía atípica y observación de infección por VIH. Evolucionó mal, complicándose a los 15 días con neumotórax y bulas pulmonares. El LDH elevado y después la inmunofluorescencia directa (+) confirmaron la etiología: P. jiroveci. El test de ELISA confirmó la pre-existencia de una infección por VIH. A pesar de una terapia enérgica con cotrimoxazol, corticoesteroides y oxígeno, el paciente falleció a los 21 días de su ingreso. Se describen las estrategias recomendadas para el manejo del neumotórax que acontece durante la neumonía por P. jiroveci en los pacientes portadores de infección por VIH.


In patients with human immunodeficiency virus infection, pneumothorax overcomes in advanced stages of the illness, associated with infections by Mycobacterium tuberculosis or Pneumocystis jiroveci, in smokers and intravenous drug users. We present a case with this unusual complication: homosexual man, 30 years of age, with a history of one month of cough, progressive dyspnea, weight loss and diarrhea. He was hospitalized with the diagnosis of atypical pneumonia, respiratory failure and a presumptive HIV infection. His clinical course was complicated by the presence of bullae and pneumothorax by day 15 of hospitalization. The existence of Pneumocystis jiroveci in sputum was confirmed by a direct immunofluorescence test. The patient was treated with sulpha-trimethoprim, steroids, oxygen, but he died 21 days after admittance. The strategies recommended for treatment of pneumothorax appeared during P. jiroveci pneumonia in HIV positive patients are summarized.


Subject(s)
Humans , Male , Adult , AIDS-Related Opportunistic Infections/complications , Pneumonia, Pneumocystis/complications , Pneumothorax/etiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Fatal Outcome , Fluorescent Antibody Technique, Indirect , Pneumonia, Pneumocystis/diagnosis , Pneumonia, Pneumocystis/drug therapy , Pneumothorax/diagnosis , Tomography, X-Ray Computed
7.
Phytother Res ; 18(3): 230-2, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15103670

ABSTRACT

In an effort to carry out a more in-depth investigation on the antimicrobial properties of H. perforatum, we have assayed different extracts (MeOH; petroleum ether; CHCl(3) and EtOAc) from the aerial parts of the plant against selected microorganisms. Growth inhibition was observed only for Gram-positive bacteria, B. subtilis and B. cereus being the most susceptible to the tested drugs. The Hypericum extract obtained with EtOAc was the most active. The main constituents of this extract, as determined by HPLC analysis, were flavonoids, hypericins and hyperforins. Incubation of the selected microorganisms with the pure chemicals resulted in a significant inhibition of their growth by hypericin, hyperforin and its stable dicyclohexilammonium salt. Flavonoids appeared inactive at all.


Subject(s)
Anti-Infective Agents/pharmacology , Gram-Positive Bacteria/drug effects , Hypericum , Phytotherapy , Plant Extracts/pharmacology , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Humans , Microbial Sensitivity Tests , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use
8.
Ann Rheum Dis ; 62(1): 94-5; author reply 95, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12480687
9.
Ann Rheum Dis ; 61(6): 554-8, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12006334

ABSTRACT

Classification criteria for Sjögren's syndrome (SS) were developed and validated between 1989 and 1996 by the European Study Group on Classification Criteria for SS, and broadly accepted. These have been re-examined by consensus group members, who have introduced some modifications, more clearly defined the rules for classifying patients with primary or secondary SS, and provided more precise exclusion criteria.


Subject(s)
Sjogren's Syndrome/classification , Decision Making , Decision Trees , Europe , Female , Humans , Male , Middle Aged , ROC Curve , Sensitivity and Specificity
10.
Ann Rheum Dis ; 61(5): 398-404, 2002 May.
Article in English | MEDLINE | ID: mdl-11959762

ABSTRACT

OBJECTIVES: To investigate the clinical and immunogenetic aspects of antibody formation against Ro/SSA and La/SSB as well as their linear B cell epitopes in patients with primary Sjögren's syndrome (pSS) from different European countries. PATIENTS AND METHODS: Ninety patients with pSS from six European centres were studied. Serum samples from all patients were tested in a control laboratory for anti-Ro/SSA and anti-La/SSB autoantibodies by RNA precipitation assay and autoantibodies to the previously reported B cell linear epitopes of Ro 60 kDa (p169-190aa and p211-232aa) and La/SSB (p147-154aa, p291-302aa, p301-318aa, and p349-364aa). DNA from 88 patients was used for the determination of HLA-DRB1, -DQA1, and -DQB1 genotypes. Analysis of the results was performed in the 88 patients who were genotyped and tested also for antipeptide antibodies. RESULTS: Antibodies to B cell epitopes of Ro 60 kDa were detected at a low frequency (range 10-37%). In contrast, B cell epitopes of La/SSB were detected frequently (range 58-86%) among the anti-La/SSB positive sera. Autoantibodies to the La/SSB epitope, p349-364aa, were significantly positively associated with longer disease duration (p<0.05), recurrent or permanent parotid gland enlargement (p<0.005), and a higher proportion of non-exocrine manifestations (p<0.005), compared with patients without autoantibodies. The presence of anti-Ro/SSA and anti-La/SSB autoantibodies was significantly associated with the presence of HLA-DRB1*03 and DQB1*02 (p=0.038 and p=0.034, respectively). This association was even more prominent and extended to HLA-DQA1*0501 when patients were stratified according the presence of autoantibodies to discrete La/SSB B cell epitopes in comparison with autoantibody negative patients (p<0.01). They were found also to be highly associated with the alleles HLA-DQB1*02 and HLA-DQA1*0501 as well as the presence of a shared amino acid motif in the region 59-69aa of DQB1 first domain (p<0.01, respectively). CONCLUSIONS: Autoantibodies against La/SSB, binding to four synthetic peptides, derived from the sequence of the La protein were identified with increased frequency in sera of patients with pSS. The formation of autoantibodies against B cell epitope analogues of La/SSB in European patients with pSS may be dependent on the presence of a permissive HLA-DQ heterodimer, most prominently represented by the HLA-DQA1*0501/DQB1*0201 heterodimer, suggesting that a model of HLA restricted presentation of La/SSB peptide determinants is crucial for the autoimmune response against La/SSB.


Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , B-Lymphocytes/immunology , RNA, Small Cytoplasmic , Ribonucleoproteins/immunology , Sjogren's Syndrome/immunology , Aged , Disease Susceptibility , Epitopes/immunology , Europe , Female , Genotype , HLA-DQ Antigens , Humans , Male , Middle Aged , Prevalence , SS-B Antigen
12.
Audiology ; 40(6): 327-35, 2001.
Article in English | MEDLINE | ID: mdl-11781046

ABSTRACT

The aim of this study is to outline the mechanisms leading cochlear cells to die. We utilized an immortalized cell line (OC-k3 cells) derived from the organ of Corti of transgenic mice in order to perform in-depth biochemical studies with no limitations on sample size and number. We probed these cells with cisplatin and gentamicin, two drugs which display in vivo undesired ototoxic side-effects. We investigated cell viability, reactive oxygen species (ROS) production and glutathione (GSH) levels and tested the effects of different concentrations of cisplatin and gentamicin from 0 to 48 h. Results show that cells undergo a dose- and treatment-time-dependent apoptosis characterized by nuclear fragmentation, integrity of the cell membrane and mitochondria, and absence of DNA endonuclease activity. During the early part of treatment, ROS production increases and intracellular GSH decreases, probably due to the activation of protein kinase C alpha. Use of antioxidants such as N-acetylcysteine, GSH and vitamin C rescues cells from apoptosis almost completely. Overall, these data indicate that ROS generation might play a central role in inducing inner ear cell apoptosis and may have an additive role in the ageing process.


Subject(s)
Apoptosis/physiology , Organ of Corti/pathology , Animals , Cell Death , Cell Line , Mice , Mice, Transgenic
13.
Lupus ; 9(6): 445-50, 2000.
Article in English | MEDLINE | ID: mdl-10981649

ABSTRACT

AIM: To determine whether the European Consensus Lupus Activity Measurement Index (ECLAM) can be used to evaluate disease activity in patients retrospectively from the data provided in their clinical charts. METHODS: The ECLAM score was calculated twice in a series of 64 consecutive SLE patients: first for each patient during the course of a standard clinical evaluation (direct-ECLAM), and then one to two weeks later solely on the basis of the data provided in the patient's clinical chart (chartECLAM). The scorings for each patient were performed by two different assessors. RESULTS: The direct-ECLAM and chart-ECLAM scores were highly correlated (Spearman's rank correlation coefficient = 0.86). The regression line was not significantly different from the identity line (t-test). The Pearson's coefficient was 0.88. The interobserver variability of the chart-ECLAM showed a low inter-rater variability. CONCLUSION: ECLAM could represent a valid and reliable instrument for the retrospective analysis of disease activity in SLE patients.


Subject(s)
Lupus Erythematosus, Systemic/physiopathology , Severity of Illness Index , Disease Progression , Female , Humans , Male , Retrospective Studies
14.
Phytomedicine ; 7(3): 239-43, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11185736

ABSTRACT

Six different mixtures of garlic distilled oils containing diallyl disulfide (DDS) and diallyl trisulfide (DTS), ranging from 1 to 51% and 88 to 38% respectively, have been assayed against a number of yeasts (C. albicans, C. tropicalis and B. capitatus), gram-positive bacteria (S. aureus and B. subtilis) and gram-negative bacteria (P. aeruginosa and E. coli). Results obtained support a specific antifungal more than an antibacterial activity and implicate DDS as the active constituent. Incubation of garlic extracts made up of 1% DDS and 88% DTS resulted, in fact, in the absence of growth inhibition against all the tested microorganisms, whereas garlic oils with higher quantities of DDS showed significant inhibitory activity, increasing with the increase of DDS amount.


Subject(s)
Allyl Compounds/pharmacology , Anti-Infective Agents/pharmacology , Garlic , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Plants, Medicinal , Sulfides/pharmacology , Yeasts/drug effects , Anti-Bacterial Agents , Humans , Microbial Sensitivity Tests , Oils, Volatile , Plant Oils/pharmacology
16.
J Comp Pathol ; 121(3): 271-6, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10486163

ABSTRACT

Archive paraffin wax-embedded sections of brain from goats and kids naturally infected with caprine arthritis-encephalitis virus (CAEV) were examined. Severe leucoencephalitis was present, with infiltration of lymphocytes, plasma cells and macrophages into the white matter, meninges and choroid plexus. On both CAEV-positive and negative (control) tissues, in-situ polymerase chain reactions were used to amplify a DNA sequence specific to the proviral Pol region. In the infected tissues, strong hybridization signals were observed, mainly located in macrophages, microglial cells, astrocytes and oligodendrocytes, and in the ependymal epithelium and choroid plexus. Positive areas were also found in the spinal cord in endothelial cells of small blood vessels. Some neurons showed a positive reaction.


Subject(s)
Arthritis-Encephalitis Virus, Caprine/isolation & purification , Brain/virology , DNA, Viral/isolation & purification , Goat Diseases/virology , Lentivirus Infections/veterinary , Animals , Brain/blood supply , Brain/pathology , Endothelium, Vascular/pathology , Endothelium, Vascular/virology , Goat Diseases/pathology , Goats/virology , Lentivirus Infections/pathology , Lentivirus Infections/virology , Microglia/pathology , Microglia/virology , Neurons/pathology , Neurons/virology , Oligodendroglia/pathology , Oligodendroglia/virology , Polymerase Chain Reaction , Proviruses/isolation & purification , Spinal Cord/pathology , Spinal Cord/virology
17.
J Rheumatol ; 26(6): 1306-11, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10381048

ABSTRACT

OBJECTIVE: Helicobacter pylori infection elicits a local and systemic immune response against bacterial antigens, including a heat-shock protein of 60 kDa (HSP60). The homology between microbial and human HSP suggests that the immune response to bacterial HSP may play a role in the pathogenesis of autoimmune disorders. Since gastric involvement and H. pylori have been reported in Sjögren's syndrome (SS), we investigated the prevalence of antibodies against H. pylori and its specific HSP60 in sera from patients with SS. METHODS: Four groups of patients were studied. Group 1, 34 patients with primary SS (pSS); Group 2.19 patients with secondary SS; Group 3, 22 patients with various autoimmune diseases and Group 4, 43 healthy controls. Serum IgG levels against HSP60 were determined by an ELISA using recombinant full length HSP60 expressed in Escherichia coli, as the antigen. To confirm the H. pylori infection, a commercial ELISA was used. RESULTS: Out of 34 patients in Group 1, 27 (79.4%) and 30 (88.2%) had antibodies against H. pylori and its HSP60, respectively. The prevalence was significantly higher than that found in Group 3 (18.2%, p < 0.0001 and 27.3%, p < 0.0001) and in Group 4 (48.8%, p < 0.005 and 37.2%, p < 0.0001) but not than that of Group 2 (48.8% and 37.2%). If the prevalence of patients either positive or negative for both antibodies was considered, a statistically significant difference was found between Group I and respectively Groups 3 and 4. CONCLUSION: The hypothetical role of HSP60 in the development of the immune response both in pSS and secondary SS seems strictly linked to the prevalence rate of H. pylori infection.


Subject(s)
Antibodies, Bacterial/blood , Chaperonin 60/immunology , Helicobacter pylori/immunology , Sjogren's Syndrome/immunology , Sjogren's Syndrome/microbiology , Adolescent , Adult , Aged , Female , Helicobacter Infections/epidemiology , Helicobacter Infections/immunology , Humans , Immunoglobulin G/blood , Middle Aged , Prevalence
18.
Farmaco ; 54(3): 191-4, 1999 Mar 31.
Article in English | MEDLINE | ID: mdl-10371032

ABSTRACT

The in vitro antibacterial and antifungal activities of a series of pyridazinoindolonic acids II against some selected representative of Gram-positive, Gram-negative bacteria and fungi have been investigated. Some interesting observations among the structural features necessary for high antibacterial activity are presented and discussed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Indoles/pharmacology , Pyridazines/pharmacology , Anti-Bacterial Agents/chemical synthesis , Indoles/chemical synthesis , Molecular Structure , Pyridazines/chemical synthesis
19.
Infect Immun ; 67(6): 3112-20, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10338528

ABSTRACT

Helicobacter pylori has been widely recognized as an important human pathogen responsible for chronic gastritis, peptic ulcers, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. Little is known about the natural history of this infection since patients are usually recognized as having the infection only after years or decades of chronic disease. Several animal models of H. pylori infection, including those with different species of rodents, nonhuman primates, and germ-free animals, have been developed. Here we describe a new animal model in which the clinical, pathological, microbiological, and immunological aspects of human acute and chronic infection are mimicked and which allows us to monitor these aspects of infection within the same individuals. Conventional Beagle dogs were infected orally with a mouse-adapted strain of H. pylori and monitored for up to 24 weeks. Acute infection caused vomiting and diarrhea. The acute phase was followed by polymorphonuclear cell infiltration, interleukin 8 induction, mononuclear cell recruitment, and the appearance of a specific antibody response against H. pylori. The chronic phase was characterized by gastritis, epithelial alterations, superficial erosions, and the appearance of the typical macroscopic follicles that in humans are considered possible precursors of MALT lymphoma. In conclusion, infection in this model mimics closely human infection and allows us to study those phases that cannot be studied in humans. This new model can be a unique tool for learning more about the disease and for developing strategies for treatment and prevention.


Subject(s)
Disease Models, Animal , Dogs , Helicobacter Infections , Helicobacter pylori , Acute Disease , Animals , Antibodies, Bacterial/immunology , Chronic Disease , Endoscopy, Gastrointestinal , Female , Helicobacter pylori/immunology , Helicobacter pylori/isolation & purification , Interleukin-8/metabolism , Male , Mice
20.
J Rheumatol ; 26(2): 498-501, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9972994

ABSTRACT

Between 1990 and 1995 a European Consensus Group carried out a multicenter study to reach agreement of the definition of disease activity in systemic lupus erythematosus (SLE). A new index, the European Consensus Lupus Activity Measurement (ECLAM) index, was developed. In a second phase of the study, a prospective survey aimed at validating ECLAM and 4 other scales as steady-state and transition indices for disease activity in SLE was completed. We present the results of this survey. A standardized clinical chart was developed, together with a computer program that could automatically calculate the ECLAM score, as well as the scores for some of the disease activity scales most widely used at present, i.e., the British Isles Lupus Assessment Group, Systemic Lupus Activity Measure, SLE Disease Activity Index, and the SLE Index Score (SIS). With the participation of 28 centers in 15 different European countries, data from 121 prospectively selected new lupus patients were collected. The validity of the 5 activity scales was assessed by comparing the computed scores for each patient to a gold standard, i.e., the physician's subjective judgment on disease activity measured using a semiquantitative scale. All the indices were found to be valid instruments for measuring disease activity in SLE in both the steady-state and transition phases. The results for the various indices closely correlated with one another. Thus, the computerized chart developed by the European Consensus Group offers a simple and reliable instrument to assess disease activity and could be used to monitor lupus patients both in clinical practice and in clinical trials.


Subject(s)
Lupus Erythematosus, Systemic/diagnosis , Pathology, Clinical/standards , Severity of Illness Index , Computer Simulation , Disease Progression , Humans , Software Validation
SELECTION OF CITATIONS
SEARCH DETAIL
...